Among US veterans, higher BMI variability was a significant risk marker associated with adverse cardiovascular events independent of mean BMI across major racial and ethnic groups.
Moderating Effect of Muscular Strength in the Association Between Cardiovascular Events and Depressive Symptoms in Middle-Aged and Older Adults-a Cross Sectional Study
Source : https://www.mdpi.com/2308-3417/9/2/36
Background: Depression and cardiovascular diseases are two main health conditions contributing to the global disease burden. Several studies indicate a reciprocal association between them. It is still unclear how changes...
Muscle-strengthening activities could be incorporated into primary and secondary preventive strategies to reduce the burden of depression in people with CVD.
Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: a Nationwide Population-Based Study
Source : https://pubmed.ncbi.nlm.nih.gov/38325629
In patients with type 2 diabetes initially diagnosed with DFC, SGLT2i are effective in significantly reducing the hospitalization for heart failure and MACE rates. SGLT2i lower the amputation rates, especially...
Patients taking SGLT2 inhibitors showed a significant decrease in rates of MACE and hospitalization for heart failure versus patients taking dipeptidyl peptidase-4 inhibitors.
Cardiovascular Outcomes With Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients With Diabetes: a Real-World Data Analysis
Source : https://pubmed.ncbi.nlm.nih.gov/38407774/
There was no statistically significant risk of cardiovascular-related events in the short or medium term in patients with diabetes who received intravitreal anti-VEGF therapy, despite a small increase in the...
Intravitreal anti-VEGF was associated with a numeric but nonstatistically significant increased risk of CV events in patients with diabetes over 12 months versus other therapies.
Risk and Incidence of Cardiovascular Disease Associated With Polycystic Ovary Syndrome
AbstractAims. We aimed to evaluate the risk of cardiovascular disease (CVD) in women with polycystic ovary syndrome (PCOS) and estimate the global incidence of
Three dietary strategies showed modest, significant reductions in CV events: energy deficit (relative risk reduction [RRR] 30), Mediterranean-like diet (RRR 40%), and salt substitution (RRR 30%).